AEGiS-SAPA: Rath drops libel claim against the Guardian South African Press AssociationImportant note: Information in this article was accurate in 2008. The state of the art may have changed since the publication date.
Click here to return to Associated Press main menu
DonateNow


Rath drops libel claim against the Guardian

South African Press Association - September 14, 2008


Vitamin entreprenur Matthias Rath has dropped a million-pound libel claim against the Guardian over his activities in townships in South Africa.

Rath sued over a series of articles by columnist Ben Goldacre that condemned Rath's claim that his pills were preferable to antiretroviral drugs, and that they could reverse the course of HIV/Aids.

South Africa, said Goldacre in one of the articles, was a haven for Aids denialism, and was afflicted by "a madness that has let perhaps hundreds of thousands of people die unnecessarily".

The Guardian said that following the dropping of the case, the High Court had ordered Rath to pay initial costs of just under a quarter of a million pounds.

Its editor, Alan Rusbridger, said: "We are very glad that Rath has dropped his libel action, doubtless designed to discourage other journalists -- in Britain and abroad -- from looking too closely at his dubious claims and methods."

Reacting on his website to the news, Goldacre, a medical doctor, said Rath had been promoting his pills in a country "where hundreds of thousands die every year from Aids under an HIV denialist president and the population is ripe for miracle cures".

"This libel case has drawn on for over a year, with the writ hanging both in my toilet, and over my head.

"I will probably now write a swift book on Rath and South Africa, as a way to make all the fascinating extra information I've had to dredge through useful to others, and to try and recoup something so that my time was not wasted.

"It will be meticulously well referenced and carefully written. I genuinely believe that the madness of the South African government's approach to Aids is one of the most important stories of our time."

In June this year, following an application brought by TAC, the Cape High Court barred Rath from claiming his product VitaCell was a treatment for HIV/Aids, and declared that the clinical trials he had been conducting in townships were unlawful.

Judge Dumisani Zondi also said Health Minister Manto Tshabalala-Msimang and her department had a duty to investigate Rath's activities.

The minister, cited as a co-respondent, opposed the application.

Rath has also claimed that antiretrovirals are toxic, and that the apartheid regime was part of a plot by the pharmaceutical industry to "conquer and control the entire African continent".


080914
SA080904


Copyright © 2008 - South African Press Association. Reproduction of this article (other than one copy for personal reference) must be cleared through the South African Press Association, Cotswold House, Greenacres Office Park, Cnr. Victory & Rustenburg Roads, VICTORY PARK, PO BOX 7766, JOHANNESBURG, 2000; Fax No: +27 11 782-1587/8, Tel No: +27 11 782-1600.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, National Library of Medicine, and donations from users like you.

Always watch for outdated information. This article first appeared in 2008. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2008. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .